Loading...

We've got a brand new version of Simply Wall St! Try it out

DFB Healthcare Acquisitions

Nasdaq:DFBH.U
Snowflake Description

Adequate balance sheet with limited growth.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
DFBH.U
Nasdaq
$303M
Market Cap
  1. Home
  2. US
  3. Diversified Financials
Company description

DFB Healthcare Acquisitions Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The last earnings update was 6 days ago. More info.


Add to Portfolio Compare Print
DFBH.U Share Price and Events
7 Day Returns
-
NasdaqCM:DFBH.U
1.5%
US Capital Markets
0.9%
US Market
1 Year Returns
-
NasdaqCM:DFBH.U
5.6%
US Capital Markets
10.5%
US Market
DFBH.U Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
DFB Healthcare Acquisitions (DFBH.U) - -4.6% -5.4% - - -
US Capital Markets 1.5% 7.5% 5.4% 5.6% 36.8% 58%
US Market 0.9% 5.2% 5.4% 10.5% 40.1% 45%
1 Year Return vs Industry and Market
  • No trading data on DFBH.U.
  • No trading data on DFBH.U.

DFBH.U Value

 Is DFB Healthcare Acquisitions undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of DFB Healthcare Acquisitions to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for DFB Healthcare Acquisitions.

NasdaqCM:DFBH.U Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model Excess Returns Model
Stable EPS Median Return on Equity from the past 5 years.
= Stable Book Value * Return on Equity
= $0.16 * 26.7%
$0.04
Book Value of Equity per Share Median Book Value from the past 5 years. $0.16
Discount Rate (Cost of Equity) See below 7.7%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NasdaqCM:DFBH.U
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Capital Markets Unlevered Beta Simply Wall St/ S&P Global 0.76
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.759 (1 + (1- 21%) (0%))
0.838
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.84
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (0.838 * 5.96%)
7.73%

Discounted Cash Flow Calculation for NasdaqCM:DFBH.U using Excess Returns Model Model

The calculations below outline how an intrinsic value for DFB Healthcare Acquisitions is arrived at using the Excess Return Model. This approach is used for finance firms where free cash flow is difficult to estimate.

In the Excess Return Model the value of a firm can be written as the sum of capital invested currently in the firm and the present value of excess returns that the firm expects to make in the future.

The model is sensitive to the Return on Equity of the company versus the Cost of Equity, how these are calculated is detailed below the main calculation.

Note the calculations below are per share.

See our documentation to learn about this calculation.

NasdaqCM:DFBH.U Value of Excess Returns
Calculation Result
Excess Returns = (Stable Return on equity – Cost of equity) (Book Value of Equity per share)
= (26.7% – 7.73%) * $0.16)
$0.03
Terminal Value of Excess Returns = Excess Returns / (Cost of Equity - Expected Growth Rate)
= $0.03 / (7.73% - 2.73%)
$0.61
Value of Equity = Book Value per share + Terminal Value of Excess Returns
= $0.16 + $0.61
$0.77
NasdaqCM:DFBH.U Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in NasdaqCM:DFBH.U represents 1.03501x of NasdaqCM:DFBH
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
1.03501x
Value per Share
(Listing Adjusted, USD)
= Value per Share (USD) x Listing Adjustment Factor
= $ 0.77 x 1.03501
$0.79
Value per share (USD) From above. $0.79
Current discount Discount to share price of $10.05
= -1 x ($10.05 - $0.79) / $0.79
-1166%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of DFB Healthcare Acquisitions is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for DFB Healthcare Acquisitions's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are DFB Healthcare Acquisitions's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqCM:DFBH.U PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in USD $0.04
NasdaqCM:DFBH Share Price ** NasdaqCM (2019-11-08) in USD $9.71
United States of America Capital Markets Industry PE Ratio Median Figure of 80 Publicly-Listed Capital Markets Companies 36.52x
United States of America Market PE Ratio Median Figure of 2,915 Publicly-Listed Companies 18.21x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of DFB Healthcare Acquisitions.

NasdaqCM:DFBH.U PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqCM:DFBH Share Price ÷ EPS (both in USD)

= 9.71 ÷ 0.04

227.46x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • DFB Healthcare Acquisitions is overvalued based on earnings compared to the US Capital Markets industry average.
  • DFB Healthcare Acquisitions is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does DFB Healthcare Acquisitions's expected growth come at a high price?
Raw Data
NasdaqCM:DFBH.U PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 227.46x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
17.6%per year
United States of America Capital Markets Industry PEG Ratio Median Figure of 36 Publicly-Listed Capital Markets Companies 1.91x
United States of America Market PEG Ratio Median Figure of 2,014 Publicly-Listed Companies 1.47x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for DFB Healthcare Acquisitions, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on DFB Healthcare Acquisitions's assets?
Raw Data
NasdaqCM:DFBH.U PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in USD $0.16
NasdaqCM:DFBH Share Price * NasdaqCM (2019-11-08) in USD $9.71
United States of America Capital Markets Industry PB Ratio Median Figure of 151 Publicly-Listed Capital Markets Companies 6.6x
United States of America Market PB Ratio Median Figure of 5,041 Publicly-Listed Companies 1.74x
NasdaqCM:DFBH.U PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqCM:DFBH Share Price ÷ Book Value per Share (both in USD)

= 9.71 ÷ 0.16

60.69x

* Primary Listing of DFB Healthcare Acquisitions.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • DFB Healthcare Acquisitions is overvalued based on assets compared to the US Capital Markets industry average.
X
Value checks
We assess DFB Healthcare Acquisitions's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Capital Markets industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Capital Markets industry average (and greater than 0)? (1 check)
  5. DFB Healthcare Acquisitions has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

DFBH.U Future Performance

 How is DFB Healthcare Acquisitions expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover DFB Healthcare Acquisitions, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
17.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is DFB Healthcare Acquisitions expected to grow at an attractive rate?
  • DFB Healthcare Acquisitions's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
  • DFB Healthcare Acquisitions's earnings growth is expected to exceed the United States of America market average.
  • Unable to compare DFB Healthcare Acquisitions's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
NasdaqCM:DFBH.U Future Growth Rates Data Sources
Data Point Source Value (per year)
NasdaqCM:DFBH.U Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 17.6%
United States of America Capital Markets Industry Earnings Growth Rate Market Cap Weighted Average 4.9%
United States of America Capital Markets Industry Revenue Growth Rate Market Cap Weighted Average 3.5%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14.2%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.2%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqCM:DFBH.U Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqCM:DFBH.U Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-09-30 -2 1
2019-06-30 -2 1
2019-03-31 -2 3
2018-12-31 -2 2
2017-12-31 0 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • DFB Healthcare Acquisitions's earnings are expected to grow by 17.6% yearly, however this is not considered high growth (20% yearly).
  • Unable to determine if DFB Healthcare Acquisitions is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqCM:DFBH.U Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from DFB Healthcare Acquisitions Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:DFBH.U Past Financials Data
Date (Data in USD Millions) EPS *
2019-09-30
2019-06-30 0.04
2019-03-31 0.09
2018-12-31 0.07
2017-12-31

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if DFB Healthcare Acquisitions will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess DFB Healthcare Acquisitions's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
DFB Healthcare Acquisitions has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

DFBH.U Past Performance

  How has DFB Healthcare Acquisitions performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare DFB Healthcare Acquisitions's growth in the last year to its industry (Capital Markets).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Unable to establish if DFB Healthcare Acquisitions's year on year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
  • Unable to compare DFB Healthcare Acquisitions's 1-year earnings growth to the 5-year average as it has been trading publicly for less than 3 years.
  • DFB Healthcare Acquisitions's 1-year earnings growth is negative, it can't be compared to the US Capital Markets industry average.
Earnings and Revenue History
DFB Healthcare Acquisitions's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from DFB Healthcare Acquisitions Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:DFBH.U Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 0.66 3.72
2019-06-30 1.33 2.91
2019-03-31 2.69 1.28
2018-12-31 2.09 1.04
2017-12-31 -0.01 0.01

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • DFB Healthcare Acquisitions has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • It is difficult to establish if DFB Healthcare Acquisitions has efficiently used its assets last year compared to the US Capital Markets industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if DFB Healthcare Acquisitions improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess DFB Healthcare Acquisitions's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Capital Markets industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
DFB Healthcare Acquisitions has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

DFBH.U Health

 How is DFB Healthcare Acquisitions's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up DFB Healthcare Acquisitions's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • DFB Healthcare Acquisitions's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • DFB Healthcare Acquisitions's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of DFB Healthcare Acquisitions's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • DFB Healthcare Acquisitions has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from DFB Healthcare Acquisitions Company Filings, last reported 1 month ago.

NasdaqCM:DFBH.U Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 5.00 0.00 0.62
2019-06-30 5.00 0.00 0.88
2019-03-31 5.00 0.00 0.74
2018-12-31 5.00 0.00 0.95
2017-12-31 0.02 0.17 0.12
  • DFB Healthcare Acquisitions has no debt.
  • DFB Healthcare Acquisitions currently has no debt however we can't compare to 5 years ago as we have no data for that period.
  • DFB Healthcare Acquisitions has no debt, it does not need to be covered by operating cash flow.
  • DFB Healthcare Acquisitions has no debt, therefore coverage of interest payments is not a concern.
X
Financial health checks
We assess DFB Healthcare Acquisitions's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. DFB Healthcare Acquisitions has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

DFBH.U Dividends

 What is DFB Healthcare Acquisitions's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from DFB Healthcare Acquisitions dividends.
If you bought $2,000 of DFB Healthcare Acquisitions shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate DFB Healthcare Acquisitions's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate DFB Healthcare Acquisitions's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqCM:DFBH.U Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Capital Markets Industry Average Dividend Yield Market Cap Weighted Average of 42 Stocks 2%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1944 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as DFB Healthcare Acquisitions has not reported any payouts.
  • Unable to verify if DFB Healthcare Acquisitions's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of DFB Healthcare Acquisitions's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as DFB Healthcare Acquisitions has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess DFB Healthcare Acquisitions's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can DFB Healthcare Acquisitions afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. DFB Healthcare Acquisitions has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

DFBH.U Management

 What is the CEO of DFB Healthcare Acquisitions's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Richard Barasch
AGE 65
TENURE AS CEO 2 years
CEO Bio

Mr. Richard Alan Barasch has been President, Chief Executive Officer and Chairman of the board of Directors at DFB Healthcare Acquisitions. since November 22, 2017. He serves as Senior Advisor at Vestar Capital Partners, Inc. Mr. Barasch serves as Chief Executive Officer and Chairman of American Progressive Life and Health Insurance Company of New York, Inc. Mr. Barasch served as the Chairman at Universal American Corp from December 1997 to April 28, 2017 and served as its Chief Executive Officer from June 1995 to April 28, 2017. He served as President of Universal American Corp. from April 1991 to March 2012. He served as President of American Progressive Life and Health Insurance Company of New York Inc. He served as Co-Chief Executive Officer and Co-President of American Pioneer Life Insurance Company. He served as President at Pennsylvania Life Insurance Company. He serves as the Chairman at American Pioneer Life Insurance Company. He serves as a Director of Navihealth, Inc. and Quest Analytics, L.L.C. He serves as a Member of the Board of Managers of Swarthmore College. He served as a Director of American Progressive since 1991. He serves as the Chairman of the Board at Turnaround for Children, The Friends of the Bronx Leadership Academy. He serves as a Director of Horace Mann Summer on the Hill and America's Health Insurance Plans. He served as Chairman of La Capitale Financial Security Insurance Company and Pennsylvania Life Insurance Company. He served as a Director of Universal American Corp since July 1988 until April 28, 2017. Mr. Barasch is a graduate of Columbia University Law School in 1979, where he was an Editor of the Law Review and graduated from Swarthmore College in 1976.

CEO Compensation
  • Insufficient data for Richard to compare compensation growth.
  • Insufficient data for Richard to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team

Richard Barasch

TITLE
President
AGE
65
TENURE
2 yrs

Chris Wolfe

TITLE
Chief Financial Officer
AGE
39
TENURE
2 yrs
Board of Directors Tenure

Average tenure and age of the DFB Healthcare Acquisitions board of directors in years:

1.8
Average Tenure
57
Average Age
  • The average tenure for the DFB Healthcare Acquisitions board of directors is less than 3 years, this suggests a new board.
Board of Directors

Richard Barasch

TITLE
President
AGE
65
TENURE
2 yrs

Mo Kaushal

TITLE
Independent Director
AGE
40
TENURE
1.8 yrs

Greg Sorensen

TITLE
Independent Director
AGE
57
TENURE
1.8 yrs

Steve Hochberg

TITLE
Independent Director
AGE
57
TENURE
1.8 yrs

Susan Weaver

TITLE
Independent Director
AGE
58
TENURE
1.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess DFB Healthcare Acquisitions's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. DFB Healthcare Acquisitions has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

DFBH.U News

Simply Wall St News

DFBH.U Company Info

Description

DFB Healthcare Acquisitions Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2017 and is based in New York, New York.

Details
Name: DFB Healthcare Acquisitions Corp.
DFBH.U
Exchange: NasdaqCM
Founded: 2017
$303,437,500
31,250,000
Website: http://
Address: DFB Healthcare Acquisitions Corp.
780 Third Avenue,
New York,
New York, 10017,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqCM DFBH Common Stock Nasdaq Capital Market US USD 17. Apr 2018
NasdaqCM DFBH.U Units Nasdaq Capital Market US USD 16. Feb 2018
Number of employees
Current staff
Staff numbers
0
DFB Healthcare Acquisitions employees.
Industry
Asset Management and Custody Banks
Diversified Financials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/11/11 00:33
End of day share price update: 2019/11/08 00:00
Last earnings filing: 2019/11/05
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.